NCT Number: NCT00403975
Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease
The purpose of this trial is to assess the effectiveness and safety of 2% diquafosol tetrasodium ophthalmic solution versus placebo following 6 weeks of treatment in subjects with mild to moderate dry eye disease.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- best corrected visual acuity in both eyes of at least +0.7
- six-month documented history of dry eye disease
- as least mild severity in 1 of the 5 dry eye symptoms
- corneal fluorescein staining of greater than or equal to 3 and less than or equal to 6 (out of 15)
Exclusion criteria
- permanent conjunctival goblet cell loss or scarring conditions
- ongoing contact lens wear
- current topical ophthalmic medication use
Treatment and study plan
Primary outcomes
-
Change in dry eye testing measures
Secondary outcomes
-
Change in dry eye testing measures and symptoms
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Registry information
Official study title
A Multi-Center, Parallel Group, Double-Masked, Randomized, Placebo-Controlled Study of Multiple Ocular Instillations of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease
Important dates
- Study start
- 2004
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Nov 27, 2006
- Registry last updated
- Feb 22, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome
NCT06210373
Dry Eye Disease, Dry Eye Syndromes
Naples, Napoli, Italy
View Trial DetailsStudy of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
NCT06370039
Conjunctival Diseases, Conjunctivitis
Rush, New York, United States
View Trial DetailsStudy of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
NCT05586152
Conjunctival Diseases, Conjunctivitis
Rush, New York, United States
View Trial DetailsA Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
NCT07284381
Dry Eye Disease, Dry Eye Syndromes
Dothan, Alabama, United States
View Trial Details